Literature DB >> 33802077

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.

Alessandra Zecca1, Valeria Barili2, Danila Rizzo2, Andrea Olivani1, Elisabetta Biasini1, Diletta Laccabue2, Raffaele Dalla Valle2, Carlo Ferrari1,2, Elisabetta Cariani3, Gabriele Missale1,2.   

Abstract

Previous studies support the role of natural killer (NK) cells in controlling hepatocellular carcinoma (HCC) progression. However, ambiguity remains about the multiplicity and the role of different NK cell subsets, as a pro-oncogenic function has been suggested. We performed phenotypic and functional characterization of NK cells infiltrating HCC, with the corresponding nontumorous tissue and liver from patients undergoing liver resection for colorectal liver metastasis used as controls. We identified a reduced number of NK cells in tumors with higher frequency of CD56BRIGHTCD16- NK cells associated with higher expression of NKG2A, NKp44, and NKp30 and downregulation of NKG2D. Liver-resident (CXCR6+) NK cells were reduced in the tumors where T-bethiEomeslo expression was predominant. HCCs showed higher expression of CD49a with particular enrichment in CD49a+Eomes+ NK cells, a subset typically represented in the decidua and playing a proangiogenic function. Functional analysis showed reduced TNF-α production along with impaired cytotoxic capacity that was inversely related to CXCR6-, T-bethiEomeslo, and CD49a+Eomes+ NK cells. In conclusion, we identified a subset of NK cells infiltrating HCC, including non-liver-resident cells that coexpressed CD49a and Eomes and showed reduced cytotoxic potential. This NK cell subset likely plays a regulatory role in proangiogenic function.

Entities:  

Keywords:  hepatocellular carcinoma; natural killer cells; tumor microenvironment

Year:  2021        PMID: 33802077      PMCID: PMC7999652          DOI: 10.3390/cells10030614

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  68 in total

Review 1.  Natural killer cells and dendritic cells: rendezvous in abused tissues.

Authors:  Alessandro Moretta
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

Review 2.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

3.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

4.  The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

Authors:  Antonino Bruno; Chiara Focaccetti; Arianna Pagani; Andrea S Imperatori; Marco Spagnoletti; Nicola Rotolo; Anna Rita Cantelmo; Francesca Franzi; Carlo Capella; Guido Ferlazzo; Lorenzo Mortara; Adriana Albini; Douglas M Noonan
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

Review 5.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

Review 6.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

7.  Evidence for discrete stages of human natural killer cell differentiation in vivo.

Authors:  Aharon G Freud; Akihiko Yokohama; Brian Becknell; Melissa T Lee; Hsiaoyin C Mao; Amy K Ferketich; Michael A Caligiuri
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

8.  Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

Authors:  Guido Ferlazzo; Ming L Tsang; Lorenzo Moretta; Giovanni Melioli; Ralph M Steinman; Christian Münz
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

Review 9.  What Defines NK Cell Functional Fate: Phenotype or Metabolism?

Authors:  Sophie M Poznanski; Ali A Ashkar
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

10.  CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma.

Authors:  Jing Jin; Binqing Fu; Xinyu Mei; Ting Yue; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  10 in total

Review 1.  Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment.

Authors:  Rosalia Busà; Matteo Bulati; Ester Badami; Giovanni Zito; Daniela Claudia Maresca; Pier Giulio Conaldi; Giuseppe Ercolano; Angela Ianaro
Journal:  Front Cell Dev Biol       Date:  2022-05-26

Review 2.  Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.

Authors:  Nicolas Jacquelot; Cyril Seillet; Fernando Souza-Fonseca-Guimaraes; Adrian G Sacher; Gabrielle T Belz; Pamela S Ohashi
Journal:  Int J Mol Sci       Date:  2021-08-22       Impact factor: 5.923

3.  Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer.

Authors:  Alessandra Zecca; Valeria Barili; Andrea Olivani; Elisabetta Biasini; Carolina Boni; Paola Fisicaro; Ilaria Montali; Camilla Tiezzi; Raffaele Dalla Valle; Carlo Ferrari; Elisabetta Cariani; Gabriele Missale
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

4.  CITEMOXMBD: A flexible single-cell multimodal omics analysis framework to reveal the heterogeneity of immune cells.

Authors:  Huan Hu; Ruiqi Liu; Chunlin Zhao; Yuer Lu; Yichun Xiong; Lingling Chen; Jun Jin; Yunlong Ma; Jianzhong Su; Zhengquan Yu; Feng Cheng; Fangfu Ye; Liyu Liu; Qi Zhao; Jianwei Shuai
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.652

Review 5.  NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton.

Authors:  E Hui Clarissa Lee; Darren Chen Pei Wong; Jeak Ling Ding
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

6.  Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes.

Authors:  Meng-Wei Ko; Kawaljit Kaur; Tahmineh Safaei; Wuyang Chen; Christine Sutanto; Paul Wong; Anahid Jewett
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

Review 7.  Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma.

Authors:  Felix Marsh-Wakefield; Angela L Ferguson; Ken Liu; Cositha Santhakumar; Geoffrey McCaughan; Umaimainthan Palendira
Journal:  Ther Adv Med Oncol       Date:  2022-07-22       Impact factor: 5.485

Review 8.  The unique role of innate lymphoid cells in cancer and the hepatic microenvironment.

Authors:  Sophie Curio; Gabrielle T Belz
Journal:  Cell Mol Immunol       Date:  2022-08-12       Impact factor: 22.096

Review 9.  Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

10.  T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma.

Authors:  Paola Fisicaro; Carolina Boni
Journal:  Cells       Date:  2022-01-06       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.